NDC properties for "Abrilada 40 MG per 0.8 ML Auto-Injector" (RxCUI 2668071)
About this data
The tables show NDC propoerties for Abrilada 40 MG per 0.8 ML Auto-Injector with the RxCUI 2668071
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Abrilada 40 MG per 0.8 ML Auto-Injector (RxCUI 2668071)
| BLA | BLA761118 |
|---|---|
| MMSL_CODE | BD38873 |
| RxCUI | 2668071 |
| SPL_SET_ID | 5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f |
| SPL_SET_ID | 81a33cfa-262f-4432-a05d-7dd260928437 |
| Prescribable Synonym | Abrilada 40 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | Abrilada 40 MG per 0.8 ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-afzb 50 MG/ML Auto-Injector [Abrilada] |
| RxNorm Synonym | Abrilada 40 MG per 0.8 ML Auto-Injector |
| RxNorm Synonym | Abrilada 50 MG/ML per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2668071) |
NDC Properties
NDC Item 00025031801
| NDC 9 | 0025-0318 |
|---|---|
| NDC 10 | 0025-0318-01 |
| NDC Item | 00025031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0025-0318 |
NDC Item 00025032501
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-01 |
| NDC Item | 00025032501 |
| Packaging | 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00025032502
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-02 |
| NDC Item | 00025032502 |
| Packaging | 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00069031801
| NDC 9 | 0069-0318 |
|---|---|
| NDC 10 | 0069-0318-01 |
| NDC Item | 00069031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0069-0318 |
NDC Item 00069032501
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-01 |
| NDC Item | 00069032501 |
| Packaging | 1 KIT in 1 CARTON (0069-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00069032502
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-02 |
| NDC Item | 00069032502 |
| Packaging | 2 KIT in 1 CARTON (0069-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00025031801
| NDC 9 | 0025-0318 |
|---|---|
| NDC 10 | 0025-0318-01 |
| NDC Item | 00025031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0025-0318 |
NDC Item 00025032501
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-01 |
| NDC Item | 00025032501 |
| Packaging | 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00025032502
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-02 |
| NDC Item | 00025032502 |
| Packaging | 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00069031801
| NDC 9 | 0069-0318 |
|---|---|
| NDC 10 | 0069-0318-01 |
| NDC Item | 00069031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0069-0318 |
NDC Item 00069032501
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-01 |
| NDC Item | 00069032501 |
| Packaging | 1 KIT in 1 CARTON (0069-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00069032502
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-02 |
| NDC Item | 00069032502 |
| Packaging | 2 KIT in 1 CARTON (0069-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00025031801
| NDC 9 | 0025-0318 |
|---|---|
| NDC 10 | 0025-0318-01 |
| NDC Item | 00025031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0025-0318 |
NDC Item 00025032501
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-01 |
| NDC Item | 00025032501 |
| Packaging | 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00025032502
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-02 |
| NDC Item | 00025032502 |
| Packaging | 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00069031801
| NDC 9 | 0069-0318 |
|---|---|
| NDC 10 | 0069-0318-01 |
| NDC Item | 00069031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0069-0318 |
NDC Item 00069032501
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-01 |
| NDC Item | 00069032501 |
| Packaging | 1 KIT in 1 CARTON (0069-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00069032502
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-02 |
| NDC Item | 00069032502 |
| Packaging | 2 KIT in 1 CARTON (0069-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00025031801
| NDC 9 | 0025-0318 |
|---|---|
| NDC 10 | 0025-0318-01 |
| NDC Item | 00025031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0025-0318 |
NDC Item 00025032501
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-01 |
| NDC Item | 00025032501 |
| Packaging | 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00025032502
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-02 |
| NDC Item | 00025032502 |
| Packaging | 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00069031801
| NDC 9 | 0069-0318 |
|---|---|
| NDC 10 | 0069-0318-01 |
| NDC Item | 00069031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0069-0318 |
NDC Item 00069032501
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-01 |
| NDC Item | 00069032501 |
| Packaging | 1 KIT in 1 CARTON (0069-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00069032502
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-02 |
| NDC Item | 00069032502 |
| Packaging | 2 KIT in 1 CARTON (0069-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00025031801
| NDC 9 | 0025-0318 |
|---|---|
| NDC 10 | 0025-0318-01 |
| NDC Item | 00025031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0025-0318 |
NDC Item 00025032501
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-01 |
| NDC Item | 00025032501 |
| Packaging | 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00025032502
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-02 |
| NDC Item | 00025032502 |
| Packaging | 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00069031801
| NDC 9 | 0069-0318 |
|---|---|
| NDC 10 | 0069-0318-01 |
| NDC Item | 00069031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0069-0318 |
NDC Item 00069032501
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-01 |
| NDC Item | 00069032501 |
| Packaging | 1 KIT in 1 CARTON (0069-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00069032502
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-02 |
| NDC Item | 00069032502 |
| Packaging | 2 KIT in 1 CARTON (0069-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00025031801
| NDC 9 | 0025-0318 |
|---|---|
| NDC 10 | 0025-0318-01 |
| NDC Item | 00025031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0025-0318 |
NDC Item 00025032501
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-01 |
| NDC Item | 00025032501 |
| Packaging | 1 KIT in 1 CARTON (0025-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00025032502
| NDC 9 | 0025-0325 |
|---|---|
| NDC 10 | 0025-0325-02 |
| NDC Item | 00025032502 |
| Packaging | 2 KIT in 1 CARTON (0025-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0025-0325 |
NDC Item 00069031801
| NDC 9 | 0069-0318 |
|---|---|
| NDC 10 | 0069-0318-01 |
| NDC Item | 00069031801 |
| Packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0069-0318 |
NDC Item 00069032501
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-01 |
| NDC Item | 00069032501 |
| Packaging | 1 KIT in 1 CARTON (0069-0325-01) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |
NDC Item 00069032502
| NDC 9 | 0069-0325 |
|---|---|
| NDC 10 | 0069-0325-02 |
| NDC Item | 00069032502 |
| Packaging | 2 KIT in 1 CARTON (0069-0325-02) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0069-0318-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-0325 |